Nu Skin Enterprises Inc (NUS) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Nu Skin Enterprises Inc   (NYSE: NUS)


Nu Skin Enterprises Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Nu Skin Enterprises Inc 's ROA in the second quarter of 2026?
Nu Skin Enterprises Inc recorded a cumulative net loss of $-216 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -15.74%.

However, within the Retail sector 159 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 610 to 1408.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -22.32 % -1.05 % 12.45 % -4.99 % -3.73 %
Y / Y Net Income Change - -98.29 % - 105.72 % -
Net Income (TTM) in million -216 55 160 110 101
Return On Assets (TTM) -15.74 % 3.75 % 10.98 % 7.74 % 7.03 %
NUS's Total Ranking # 1408 # 610 # 807 # 911 # 2898
Total Assets (TTM) in million 1,122 1,377 1,577 1,424 1,444
Seq. Total Assets Change -18.54 % -12.68 % 10.69 % -1.34 % 3.76 %
Seq. Net Income Change - -87.33 % -15.15 % -19.13 % -80.36 %



Return On Assets Company Ranking
Within: No.
Industry # 8
Sector # 160
Overall # 3345

Return On Assets Statistics
High Average Low
23.89 %
8.89 %
-16.25 %
(Dec 31 2013)   (Jun 30 2026)





Financial Statements
Nu Skin Enterprises Inc 's Assets $ 1,122 million NUS's Balance sheet
Nu Skin Enterprises Inc 's Income $ -250 million Quarterly NUS's Income Statement
NUS's Income by Division See NUS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 0.5 % -18.65 % -0.34 % -3.59 % -0.82 %
Total Assets in million 1,405 1,398 1,719 1,725 1,789
Y / Y Net Income Change - - -91.8 % -28.85 % -23.04 %
Net Income in million 160 -147 9 105 147
Annual Return On Assets 11.4 % -10.48 % 0.5 % 6.07 % 8.23 %




Comment on NUS's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 11.4 % compared to prior year, due to annual net income growth of % to $160.20 million, while value of Nu Skin Enterprises Inc 's overall assets grew just by 0.5 % to $1,405.31 million, compared to $1,405.31 a year before.


More Return On Assets Ratios
NUS's' Return on Assets at Yahoo Finance
Pharmacy Services & Retail Drugstore Industry Return On Assets Trends and Statistics
Retail Sector Roa Statistics
Roa Trends for overall market
NUS's Roa Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NUS's Competitors
Subscribers only: Roa for Nu Skin Enterprises Inc 's Suppliers
Subscribers only: Return On Assets for NUS's Customers

You may also want to know
NUS's Roi NUS's Inventory Turnover Ratio NUS's Growth Rates NUS's Dividend Comparisons
NUS's Profitability Ratios NUS's Asset Turnover Ratio NUS's Dividend Growth
NUS's Roe NUS's Valuation Ratios NUS's Financial Strength Ratios NUS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Retail Sector ROA


Date modified: 2026-09-12T06:18:48+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.